BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 87.7% in October

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 1,000 shares, a drop of 87.7% from the September 30th total of 8,100 shares. Based on an average daily volume of 10,400 shares, the short-interest ratio is presently 0.1 days.

BioNxt Solutions Stock Down 3.7 %

Shares of BNXTF stock opened at $0.19 on Friday. The company’s fifty day simple moving average is $0.17 and its 200-day simple moving average is $0.22. BioNxt Solutions has a 12 month low of $0.00 and a 12 month high of $0.57. The firm has a market cap of $21.47 million, a PE ratio of -3.80 and a beta of 0.85.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings data on Wednesday, August 28th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.